ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025
Reply to: Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial Insights.
Phuoc T Tran, Jarey H Wang, Chad Tang, Ana P Kiess
Abstract read
In one paragraphArticle in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
4 authors.
Phuoc T TranPhuoc T. Tran, MD, PhD, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD; Phuoc T. Tran, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; Chad Tang, MD, Department of GU Radiation Oncology, MD Anderson Cancer Center, Houston, TX; and Ana P. Kiess, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-0147-0376 Jarey H WangPhuoc T. Tran, MD, PhD, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD; Phuoc T. Tran, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; Chad Tang, MD, Department of GU Radiation Oncology, MD Anderson Cancer Center, Houston, TX; and Ana P. Kiess, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0001-9038-4674 Chad TangPhuoc T. Tran, MD, PhD, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD; Phuoc T. Tran, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; Chad Tang, MD, Department of GU Radiation Oncology, MD Anderson Cancer Center, Houston, TX; and Ana P. Kiess, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-5915-1327 Ana P KiessPhuoc T. Tran, MD, PhD, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD; Phuoc T. Tran, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; Chad Tang, MD, Department of GU Radiation Oncology, MD Anderson Cancer Center, Houston, TX; and Ana P. Kiess, MD, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0001-6928-3852 Funding
Radiobioeffect Modeling of αRPTP01CA272222 · NCI · JOHNS HOPKINS UNIVERSITY · PI Ana Ponce Kiess · 2023 to 2026
$12.8MResource Sharing CoreU54CA273956 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Amit Sawant, Nicole L Simone · 2022 to 2026
$8.9MTOPIC 368: TREATMENT OPTIMIZATION BY COMBINED A-EMITTER (ARPT)/RADIOTHERAPY (XRT) DOSIMETRY FOR PROSTATE CANCER PATIENTS75N91019C00040 · NCI · RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC · PI GHALY, MICHAEL · 2019 to 2019
$2.0MNCI NIH HHS 75N91019C00040NCI NIH HHS P01 CA272222NCI NIH HHS U54 CA273956
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID41043087
PMCPMC12614352
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390